Txoj Kev Siv thiab Txoj Kev: Kev sib koom tes, kev sib haum xeeb thiab yeej-yeej
cov khoom

Cov khoom

Linagliptin CAS: 668270-12-0 Chaw tsim tshuaj paus

Linagliptin (lub npe lag luam Tradjenta thiab Trajetna) yog ib qho inhibitor ntawm dipeptidyl peptidase-4 (DPP-4) uas tau pom zoo los ntawm US FDA thaum lub Tsib Hlis 2011 rau kev kho mob ntshav qab zib hom 2 nrog rau kev noj haus thiab kev tawm dag zog.Linagliptin (BI-1356) tau piav qhia tias yog lub zog muaj zog xaiv, qeeb qeeb thiab ntev ua yeeb yam inhibitor ntawm DPP-4.Linagliptin tau tshwm sim los ntawm kev ua kom zoo dua ntawm xanthine-raws li DPP-4 inhibitors nrog thawj cov hlau lead pom los ntawm kev sib tw HTS.


Product Detail

Khoom cim npe

Kev siv thiab cuam tshuam

Linagliptin (TrajentaR, TradjentaTM, TrazentaTM, TrayentaTM) yog qhov ncauj, xaiv ntau yam inhibitor ntawm dipeptidyl peptidase-4 thiab yog thawj tus neeg sawv cev ntawm nws cov chav kawm kom tshem tawm feem ntau ntawm txoj hauv kev tsis muaj lub raum.Linagliptin yog siv rau ib hnub ib zaug rau kev kho mob ntawm cov neeg laus uas muaj ntshav qab zib hom 2.Linagliptin ua kom txo cov ntshav qabzib hauv cov ntshav los ntawm inhibiting cov enzyme DPP-4, yog li tiv thaiv kev degradation ntawm cov tshuaj hormones incretin (glucagon-zoo li peptide-1 [GLP]. -1] thiab glucose-dependent insulinotropic peptide) thiab txo qis cov piam thaj tom qab kev mus ncig.

Khoom qauv

Phau Ntawv Nkauj 285(1)
Phau Ntawv Nkauj 286(1)

Cov khoom ntim:

202 (1)

Cov ntaub ntawv ntxiv:

Kev sib xyaw C25H28N8O2
Assay 99%
Qhov tshwm sim Dawb hmoov
CAS Nr. 668270-12-0
Ntim 25 KG
Txee lub neej 2 xyoo
Cia Khaws rau hauv qhov chaw txias thiab qhuav
Daim ntawv pov thawj ISO.

  • Yav dhau los:
  • Tom ntej:

  • Sau koj cov lus ntawm no thiab xa tuaj rau peb